The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - Baseline characteristics of the study population

Cardiology (Switzerland)

Volumn 110, Issue 4, 2008, Pages 271-282

  Fox, Kim ^a   Ferrari, R ^b   Ford, I ^b   Steg, P G ^b   Tendera, M ^b   Cohen Arazi, H ^b   Nul, D R ^b   Ahuad Guerrero, R A ^b   Luciardi, H L ^b   Sinisi, V A ^b   Perna, E R ^b   Schygiel, P O ^b   Sanjurjo, M S ^b   Fernandez, A A ^b   Del Valle Lobo Marquez, L L ^b   Fuselli, J J ^b   Hasbani, E ^b   Ibanez J O ^b   Cartasegna, L R ^b   Lembo, L A ^b   Thierer, J ^b   Varini, S ^b   Buscema, J J ^b   Orlandini, A D ^b   Bustos, B ^b   Guzman L A ^b   Luquez, H A ^b   Amuchastegui, M ^b   Allall, O A ^b   Iglesias, R M ^b   Sokn, F J ^b   Montana O R ^b   Sanchez, A ^b   Vogel, D ^b   Eber, B ^b   Huber, K ^b   Lang, I ^b   Pichler, ^b   Dendale, P A ^b   Vanderheyden, M ^b   van Mieghem, W ^b   Chenu, P ^b   Friart, A ^b   Missault, L ^b   Vachiery, J L ^b   Materne, P ^b   Francois B A ^b   Sirakova, V ^b   Penkov, N ^b   Georgiev, B ^b   Grigorov, M ^b   Taseva, T ^b   Nachev, C ^b   Guenova, D ^b   Perchev, I ^b   Denchev, S ^b   Donova, T ^b   Torbova, S ^b   Goudev, A ^b   Raev, D ^b   Gotchev, D ^b   Tzekova, M ^b   Chompalova, B ^b   Hergeldjieva, V ^b   Kamenova, Z ^b   Dzhurzdhev, A ^b   Tardif, J C ^b   Talbot, P ^b   Yao, L ^b   Ma, P ^b   Constance, C ^b   Bernstein, V ^b   Heath, J ^b   Lalani, A ^b   Haddad, H ^b   To, T B ^b   Pandey, S ^b   Desrochers, D ^b   Fortin, C ^b   Poirier, P ^b   Savard, D ^b   Baird, M ^b   Lonn, E ^b   Coutu, B ^b   Vertes, G E ^b   Rebane, T ^b   Kouz, S ^b   Raco, D ^b   Rajda, M ^b   Parker, J O ^b   Glanz, A ^b   Lepage, S ^b   Parker, J D ^b   Klinke, W P ^b   Rupka, D ^b   Hill, L L ^b   Nawaz, S ^b   Chehayeb, R ^b   Lauzon, C ^b   Matangi, M ^b   Syan, G S ^b   Hu, D ^b   Lv, S ^b   Yan, X ^b   Gai, L ^b   Ge, J B ^b   Dong, Y ^b   Sun, Y ^b   Yuan, Z ^b   Zhang, F ^b   Wang, X ^b   Wang, W ^b   Hradec, J ^b   Florian, J ^b   Sulda, M ^b   Spinar, J ^b   Fabik L ^b   Stipal R ^b   Kaislerova M ^b   Vitovec, J ^b   Vojtisek P ^b   Krejcova, H ^b   Maratka, T ^b   Sochor, K ^b   Marcinek, G ^b   Povolny J ^b   Jerabek O ^b   Karetova D ^b   Vojacek, J ^b   Lavicka, V ^b   Vencour, D ^b   Kotik L ^b   Kuchar, J ^b   Drazka, J ^b   Penicka, M ^b   Kryza, R ^b   Soucek, M ^b   Ballek, L ^b   Spacek, R ^b   Bronnum Schou J ^b   Torp Pedersen, C ^b   Nielsen, T ^b   Markenvard, J ^b   Tuxen, C ^b   Hildebrandt, P ^b   Sejersen, H ^b   Rokkedal, J ^b   Ralfkiaer, N ^b   Agner, E ^b   Skagen, K ^b   Roseva NIelsen, N ^b   Vigholt, E ^b   Dodt, K K ^b   Lind Rasmussen, L ^b   Pedersen, L ^b   Stentebjerg, S E ^b   Asklund, M ^b   Klarlund, K ^b   Haghfelt, T ^b   Gotzsche L ^b   Rickers, H ^b   Kober L ^b   Jensen, G ^b   Dahlstrom C G ^b   Gotzsche O ^b   Egstrup, K ^b   Petersen, J ^b   Larsen, J ^b   McNair, A ^b   Jakobsen, T ^b   Larsen, C T ^b   Eha, J ^b   Vahula, V ^b   Averina, O ^b   Viigimaa, M ^b   Sildmae S ^b   Kolbassova, O ^b   Melin, J ^b   Peuhkurinen, K ^b   Harjola, V P ^b   Luoma, J ^b   Ovize, M ^b   Sellier, P ^b   Barthelemy, J C ^b   Beaune, J ^b   Magnin, D ^b   Dambrine, P ^b   Khalife, K ^b   Wolf, J E ^b   Roudaut, R ^b   Gabrovescu, M ^b   Dubois Rande, J L ^b   Galinier, M ^b   Genest, M ^b   Mansourati, J ^b   Aliot, E ^b   Carlioz, R ^b   Cherbi, C ^b   Slama, M ^b   Colin, P ^b   Decoulx, E ^b   Escande, M ^b   Fournier, P Y ^b   Galley, D ^b   Khanoyan, P ^b   Jaboureck, O ^b   Leborgne, L ^b   Mann, H ^b   Pierre Justin, E ^b   Roynard, J L ^b   Soto, F X ^b   Bourdon, A ^b   Bauer, F ^b   Belin, A ^b   Boudahne, A ^b   Bouvier, J M ^b   Chati, Z ^b   Chevalier, J M ^b   Chevrier, J ^b   Doucet, B ^b   Drawin, T ^b   Mansour, N E ^b   Funck, F ^b   Godenir, J P ^b   Guillot, J P ^b   Gully, C ^b   Habib, G ^b   Kahn, J C ^b   Koenig, A ^b   Martelet, M ^b   Matina, D ^b   Gay, A ^b   Meurice, T ^b   Perret, T ^b   Riou, A ^b   Thisse, J Y ^b   Demarcq, J M ^b   Bodur, G ^b   Claudon, O ^b   Lemoine, C ^b   Roul, G ^b   Olive, T G ^b   Huyghe de Mahenge, A ^b   Meinertz, T ^b   Baumann, G ^b   Bohm M ^b   Cieslinski, G ^b   Figulla, H R ^b   Gonska, B D ^b   Hasenfuss, G ^b   Heckel, D ^b   Hoppe, U ^b   Katus, H ^b   Kombacher H D ^b   Muller O ^b   Munzel T ^b   Nienaber, C ^b   Oeff, M ^b   Rupprecht, H J ^b   von Schacky, C ^b   Schmidt, J ^b   Schreckenberg, A ^b   Schuler, G ^b   Schultheiss, H P ^b   Seidl, K ^b   Steindorf, J ^b   Strasser, R ^b   Werdan, K ^b   Hengstenberg, C ^b   Haverkamp, W ^b   Windstetter, U ^b   Al Zoebi, A ^b   Potsch T ^b   Proskynitopoulos, N ^b   Baar, M ^b   Winkelmann, B R ^b   Jeserich, M ^b   Tammen, A ^b   Appel, K F ^b   Fries, P ^b   Ammer, K ^b   Droese, ^b   Bergmann, K ^b   Bott, J ^b   Lange, R ^b   Taggeselle, J ^b   Rummel, R ^b   Kleinertz, K ^b   Deissner, M ^b   Drescher, T ^b   Zahorsky, R ^b   Schenkenberger, I ^b   Grooterorst, P ^b   Frick, H M ^b   Spengler, U ^b   Jahnke, N ^b   Bauknecht, C ^b   Lehmann, G ^b   Spanier, C ^b   Wolde, C H ^b   Natour, M ^b   Bosch, R ^b   Rudell U ^b   Gola, G ^b   Hering, R ^b   Heuer, H ^b   Gartner J ^b   Vardas, P ^b   Kremastinos, D ^b   Anastasiou Nana, M ^b   Kallikazaros, I ^b   Theodorakis, G ^b   Kyriakides, Z ^b   Pyrgakis, V N ^b   Siogas, K ^b   Kapordelis, C ^b   Apostolou, T ^b   Karvounis, H ^b   Papadopoulos, C ^b   Tziakas, D ^b   Tryposkiadis, F ^b   Koliopoulos, N ^b   Alexopoulos, D ^b   Fotiadis, I ^b   Kolettis, T ^b   Manolis, A ^b   Pras, A ^b   Lee, K ^b   Borbola, J ^b   Preda U ^b   Tomcsanyi J ^b   Edes, I ^b   Nagy, A ^b   Lippai, J ^b   Regos, L ^b   Toth K ^b   Takacs J ^b   Cziraki A ^b   Matoltsy, A ^b   Sido Z ^b   Nagy, L ^b   Nyaradi A ^b   Mohay, A ^b   Rumi, G ^b   Polgar P ^b   Zamolyi K ^b   Tahy, A ^b   Piros, G ^b   Veress, G ^b   Barsi, B ^b   Kovacs A ^b   Sereg, M ^b   Palinkas A ^b   Sarman P ^b   Juhasz A ^b   Mohacsi A ^b   Harmati, L ^b   Lupkovics, G ^b   Dezsi C A ^b   Nagy, K ^b   Vegh, G ^b   Varadi A ^b   Farsang, C ^b   Lakatos, F ^b   Barton, J ^b   Crean, P ^b   Foley, D ^b   Daly, K ^b   De Luca, I ^b   Urbinati, S ^b   Zanetta, M ^b   Porcu, M ^b   Cocchieri, M ^b   Buia, E ^b   Minneci, C ^b   Leghissa, R ^b   Della Cassa, S ^b   Pizzimenti, G ^b   Ingrilli, F ^b   Fuscaldo, G ^b   Bellone, E ^b   Pulitano, G ^b   Santini, M ^b   Uguccioni, M ^b   Carbonieri, E ^b   Barbuzzi, S ^b   Alberti, E ^b   Proto, C ^b   Pettinati, G ^b   Cosmi, F ^b   Colombo, A ^b   De Cristofaro, M ^b   Ambrosio, G ^b   Maresta, A ^b   De Matteis, C ^b   Mos, L ^b   Giustiniani, S ^b   Paparoni, S ^b   Proietti, G ^b   Giannuzzi, P ^b   Cardona, N ^b   Perna, B ^b   Gavazzi, A ^b   Capucci, A ^b   Reggianini, L ^b   Zanini, R ^b   Keisa, M ^b   Erglis, A ^b   Ozolina, M A ^b   Gersamija, A ^b   Gailiss, E ^b   Volans, E ^b   Stoma, M ^b   Libins, A ^b   Grabauskiene, V ^b   Petrulioniene, Z ^b   Berukstis, E ^b   Kibarskis, A ^b   Zaliunas, R ^b   Marcinkeviciene, J ^b   Naudziunas, A ^b   Kirkutis, A ^b   Varoneckas, G ^b   Cornel, J H ^b   Hamer, B J ^b   Hoedemaker, G ^b   van den Berg, B J ^b   Somer, S T ^b   van der Veen, M ^b   van Rossum, P ^b   Bartels, G L ^b   van Vlies, B ^b   Lionarons, R J ^b   Dijkgraaf, R ^b   Wesdorp, J C ^b   Kragten, J A ^b   Fast, J ^b   de Milliano, P A ^b   van Rugge, F P ^b   Hoogslag, P A ^b   Gobel E J ^b   Leenders, C M ^b   van der Heijden, R ^b   Swart, H ^b   van Beek, G J ^b   van der Zwaan, C ^b   Holwerda, N J ^b   Winter, J B ^b   Galema, T W ^b   Voors, A A ^b   Kirkels, J H ^b   Jaarsma, W ^b   Zwart, P A ^b   Thijssen, H ^b   Linssen, G C ^b   Verheul, J A ^b   Maas, A H ^b   Willems, A R ^b   Nagelsmit, M J ^b   Freericks, M P ^b   Pinto, Y M ^b   Bruning, T A ^b   Michels, H M ^b   Withagen, A J ^b   Jap Tjoen San, W T ^b   Robles De Medina, R ^b   Nierop, P R ^b   Daniels, M C ^b   van Kempen, L H ^b   Herrman, J P ^b   van Wijk, L M ^b   Atar, D ^b   Myhre, E P ^b   Dickstein, K ^b   Musial, W ^b   Pulkowski, G ^b   Sinkiewicz, W ^b   Kubica, J ^b   Janik, K ^b   Rynkiewicz, A ^b   Miekus, P ^b   Szpajer, M ^b   Zadrozna, Z ^b   Krzeminska Pakula, M ^b   Goch, J ^b   Krynicki, R ^b   Trusz Gluza, M ^b   Janion, M ^b   Zinka, E ^b   Kawecka Jaszcz, K ^b   Piwowarska, W ^b   Piotrowski, W ^b   Bloch, C ^b   Trojnar, R ^b   Targonski, R ^b   Pluta, W ^b   Krzciuk, M ^b   Achremczyk, P ^b   Kuzniar, J ^b   Baska, J ^b   Ruszkowski, P ^b   Drozdowski, P ^b   Kurowski, M ^b   Krupa, E ^b   Slowinski, S ^b   Skura, M ^b   Pusz, T ^b   Jaworska, K ^b   Dluzniewski, M ^b   Opolski, G ^b   Piepiorka, M ^b   Andrzejak, R ^b   Wrabec, K ^b   Ponikowski, P ^b   Loboz Grudzien, K ^b   Wodniecki, J ^b   Kalarus, Z ^b   Tracz, W ^b   Kozlowski, A ^b   Ruzyllo, W ^b   Mazurek, W ^b   Szolkiewicz, M ^b   Paisana Lopes, J P ^b   Carvalho, N ^b   Teixeira, M ^b   Ferreira Da Silva, G ^b   Aguiar, J ^b   Lousada, N ^b   Salgado, A ^b   Providencia, L A ^b   Freitas, J ^b   Oliveira Soares, A ^b   Capalneanu, R ^b   Macarie, C ^b   Bruckner, I ^b   Cinteza, M ^b   Nanea, T ^b   Dorobantu, M ^b   Vintila, M ^b   Dan, G A ^b   Dimulescu, D R ^b   Arsenescu, C ^b   Ionescu, D D ^b   Dragulescu, I S ^b   Avram, R ^b   Opris, M ^b   Manitiu, I ^b   Craiu, E ^b   Babes, K ^b   Tase, A ^b   Tintoiu, I ^b   Apetrei, E ^b   Olinic, N C ^b   Radoi, M ^b   Minescu, B ^b   Tanaseanu, C M ^b   Sinescu, C J ^b   tomescu, M ^b   Loariu, C ^b   Carasca, E ^b   Datcu, M D ^b   Dumitrascu, D L ^b   Ionascu Fometescu, C R ^b   Pop, C ^b   Radu, I ^b   Vladoianu, M ^b   Kiss, L ^b   Toplnitchi, L ^b   Aroutiounov, G P ^b   Beloussov, Y B ^b   Vasyuk, Y A ^b   Vertkine, A L ^b   Zadionchenko, V S ^b   Zateyshchikov, D A ^b   Ya Ivleva, A ^b   Karpov, Y A ^b   Kisliak, O A ^b   Kobalava, J D ^b   Yu Konyakhin, A ^b   Kukes, V G ^b   Yu Mareev, V ^b   Mkrtchyan, V R ^b   Orlov, V A ^b   Sidorenko, B A ^b   Stryuk, R I ^b   Tereschenko, S N ^b   Shpektor, A V ^b   Pozdnyakov, Y M ^b   Khrustalev, O A ^b   Yakusevich, V V ^b   Yakushin, S S ^b   Azarin, O G ^b   Karpov, Y B ^b   Moiseeva, O M ^b   Perepech, N B ^b   Sayganov, S A ^b   Svistov, A S ^b   Sorokin, L A ^b   Shlyakhto, E V ^b   Lopatin, Y M ^b   Nedogoda, S V ^b   Arkhipov, M V ^b   Kuimov, A D ^b   Tsyba, L P ^b   Yakhontova, P K ^b   Chumakova, G A ^b   Barbarsh, O L ^b   Bart, B Y ^b   Bychkova, L ^b   Golukhova, E ^b   Zhilyaev, E V ^b   Rodoman, G V ^b   Rudnev, D V ^b   Tankhilevich, B M ^b   Shostak, N A ^b   Kastanaian, A A ^b   Pimenov, L T ^b   Murin J ^b   Kamensky G ^b   Gonsorcik J ^b   Bada, V ^b   Pella, D ^b   Sojka, G ^b   Vahala, P ^b   Bugan V ^b   Kmec, J ^b   Micko, K ^b   Rakovec, P ^b   Kanic, V ^b   Skrabl Mocnik, F ^b   Slemenik Pusnik, C ^b   Melihen Bartolic, C ^b   Markez, J ^b   Macaya De Miguel, C ^b   Grande, A ^b   Jimenez Navarro, M ^b   Romero Hinojosa, J A ^b   Bertomeu Martinez, V ^b   Paz Bermejo, M A ^b   Illa Gay, J ^b   Gusi Tragant, G ^b   Calvo Gomez, C ^b   Iglesias Cubero, G ^b   Balaguer Recena, J ^b   Lopez Garcia Aranda V ^b   Caparos Valderrama, J ^b   Iglesias Alonso, L F ^b   San Roman Calvar A ^b   Fernanez Aviles, F ^b   Perez Villa, F ^b   Bruguera Cortada, J ^b   Fernandez Alvarez, R ^b   Noriega Peiro, F ^b   Calvo Iglesias, F ^b   Sevilla Toral, B ^b   Lopez Bescos L ^b   Garcia de Burgos, F ^b   Sola Casado, R ^b   Galve, E ^b   Casares Garcia, G ^b   Delborg, M ^b   Herlitz, J ^b   Ullman, B ^b   Blomgren, J ^b   Bandh, S ^b   Ohlin, H ^b   Dubach, P ^b   Gallino, A ^b   Hess, O ^b   Moccetti, T ^b   Eeckhout, E ^b   Vontobel, H ^b   Delabays, A ^b   Erol, K ^b   Kozan, O ^b   Mutlu, B ^b   Ergene, O ^b   Acarturk, E ^b   Yilmaz, H ^b   Ural, D ^b   Parkhomenko, O ^b   Polyvoda, S ^b   Dyadyk, A ^b   Vatutin, M ^b   Karpenko, O ^b   Kubyshkin, V ^b   Rudenko, L ^b   PUtintsev, V ^b   Krayz, I ^b   Kovalsky, I ^b   Rudyk, Y ^b   Yurlov, V ^b   Mostovoy, Y ^b   Rishko, M ^b   Barna, O ^b   Slyvka, Y ^b   Perepelytsya, M ^b   Seredyuk, N ^b   Bazylevych, A ^b   Glushko, L ^b   Tashchuk, V ^b   Girina, O ^b   Vizir, V ^b   Pertseva, T ^b   Vlasenko, M ^b   Goloborodko, B ^b   Kolomiets, S ^b   Dzyak, G ^b   Sharuk, O ^b   Storozhuk, B ^b   Kovalenko, V ^b   Khomazyuk, T ^b   Soldatchenko, S ^b   Lutay, M ^b   Zharinov, O ^b   Serkova, V ^b   Korkushko, O ^b   Korzh, O ^b   Netyazheko, V ^b   Sakharchuck, I ^b   Stadnyuk, L ^b   Bereznyakov, I ^b   Semidotska, Z ^b   Kolchin, Y ^b   Voronkov, L ^b   Tseluyko, V ^b   Amosova, K ^b   Batuschkin, V ^b   Hall, A ^b   Lindsay, S ^b   Moriarty, A ^b   Kadr, H ^b   Francis, C M ^b   Saltissi, S ^b   Rozkovec, A ^b   Groves, P ^b   Crook, J R ^b   Purvis, J ^b   Brooksby, P ^b   Stewart, M ^b   Dutka, D ^b   Timmis, A ^b   Baig, M W ^b   Brady, A ^b   Williams, S ^b   Brooks, N ^b   Greaves, K ^b   more..

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Coronary artery disease; Heart rate; Ivabradine; Left ventricular dysfunction; Mortality

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; PLACEBO; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 46349083598     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112412     Document Type: Article

References (69)

1. Kannel WB, Kannel C, Paffenbarger RE Jr, Cupples LA: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494.
2. Palatini P, Julius S: Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004;26:637-644.
3. Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-974.
4. Fox K, Borer JS, et al; Heart Rate Working Group: Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-830.
5. Disegni E, Goldbourt U, Reicher-Reiss H, et al: The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group (Secondary Prevention Reinfarction Israeli Nifedipine Trial). J Clin Epidemiol 1995;48:1197-1205.
6. Marchioli R, Avanzini F, et al; GISSI-Prevenzione Investigators: Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001;22:2085-2103.
7. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S: The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-36.
8. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS: Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977-982.
9. Daly CA, De Stavola B, Lopez Sendon JL, Tavazzi L, Boersma E, Clemens F, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheught F, Fox KM: Predicting prognosis in stable angina - results from the Euro Heart Survey of stable angina: prospective observational study. BMJ 2006;332:262-267.
10. Freemantle N, Cleland J, Young P, Mason J, Harrison J: Beta-blockade after myocardial infarction: systematic review and metaregression analysis. BMJ 1999;318:1730-1737.
11. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task Force on Beta-Blockers of the European Society of Cardiology: Expert consensus document on β-adrenergic receptor blockers. Eur Heart J 2004;25:1341-1362.
12. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:1116-1143.
13. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Pierard L, Remme WJ; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 2005;26:1115-1140.
14. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholtz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006;113:2363-2372.
15. Kjekshus JK: Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
16. Gundersen T, Grottum P, Pedersen T, Kjekshus JK: Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986;58:20-24.
17. Kjekshus J, Gullestad L: Heart rate as a therapeutic target in heart failure. Eur Heart J Suppl 1999;1(suppl H):H64-H69.
18. Lechat P, Hulot J-S, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H: Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001;103:1428-1433.
19. Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, Di Lenarda A, Komajda M, Remme WJ, Lutiger B, Scherhag A, Lukas MA, Charlesworth A, Poole-Wilson PA: Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005;26:2259-2268.
20. Thackray SD, Ghosh JM, Wright GA, Witte KK, Nikitin NP, Kaye GC, Clark AL, Tweddel A, Cleland JG: The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J 2006;152:713.e9-e13.
21. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM: Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113:203-212.
22. Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E: National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J 2006;152:454.e1-e8.
23. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J: The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2. Treatment. Eur Heart J 2003;24:464-474.
24. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
25. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P: Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 2000;283:1295-1302.
26. Lenzen MJ, Boersma E, Scholte op Reimer WJM, Balk AHMM, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JGF: Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005;26:2706-2713.
27. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A: Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005;294:1240-1247.
28. Butler J, Khadim G, Belue R, Chomsky D, Dittus RS, Griffin M, Wilson JR: Tolerability to beta-blocker therapy among heart failure patients in clinical practice. J Card Fail 2003;9:203-209.
29. Bois P, Bescond J, Renaudon B, Lenfant J: Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996;118:1051-1057.
30. f channels by ivabradine. J Gen Physiol 2002;120:1-13.
31. Bucchi A, Tognati R, Milanesi M, Baruscotti M, DiFrancesco D: Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J Physiol 2006;572:335-346.
32. (f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004;64:1757-1765.
33. Fox K, Garcia MA, Ardessino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K: Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-1381.
34. Camm AJ, Lau CP: Electrophysiological effects of a single intravenous administration if ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D 2003;4:83-89.
35. Joannides R, Moore N, Iacob M, Compagnon P, Lerebours G, Menard JF, Thuillez C: Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol 2006;61:127-137.
36. (f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology 2003;100:149-155.
37. f inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817-823.
38. f inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005;26:2529-2536.
39. f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. Am Heart J 2006;152:860-866.
40. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
41. Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K; Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees: Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 2004;110:2618-2626.
42. Cleland JGF, Goode K, Erhardt L, Remme WJ, Charlesworth A, Poole-Wilson PA, Di Lenarda A, Hanrath P, Komajda M, Metra M, Swedberg K, Torp-Pedersen C: A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET). Cardiovasc Drugs Ther 2004;18:139-152.
43. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GBJ, Weintrub WS; COURAGE Trial Research Group: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516.
44. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
45. Gomma AH, Fox KM: The EUROPA trial: design, baseline demography and status of the substudies. Cardiovasc Drugs Ther 2001;15:169-179.
46. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999;20:725-741.
47. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL; PEACE Trial Investigators: Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004;351:2058-2068.
48. Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-225.
49. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kaselein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435.
50. Shibata MC, Flather MD, Wang D: Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001;3:351-357.
51. Daly CA, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM: The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 2005;26:1011-1022.
52. Cowie MR, Fox KF, Wood DA, Metcalfe C, Thompson SG, Coats AJS, Poole-Wilson PA, Sutton GC: Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002;23:877-885.
53. McMurray J, Ostergren J, Pfeffer M, Swedberg K, Granger C, Yusuf S, Held P, Michelson E, Olofsson B: Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail 2003;5:261-270.
54. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR Jr, Chaitman BR, Kaiser GC, Alderman E, Killip T 3rd: Long-term survival of medically-treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994;90:2645-2657.
55. Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F, Portnay EL, Marshalko SJ, Radford MJ, Krumholz HM: The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003;42:736-742.
56. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA: Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005;112:3738-3744.
57. Gibbons RJ, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). http://www.acc.org/qualityandscience/clinical/ guidelines/stable/stable_clean.pdf.
58. Boudelas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM: Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation 1979;60:164-169.
59. Nabel EG, Selwyn AP, Ganz P: Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 1990;81:850-859.
60. Sambuceti G, Marzilli M, Marraccini P, Schneider-Eicke J, Gliozheni E, Parodi O, L'Abbate A: Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 1997;95:2652-2659.
61. Hinderliter A, Miller P, Bragdon E, Ballenger M, Sheps D: Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand. J Am Coll Cardiol 1991;18:405-412.
62. Andrews TC, Fenton T, Toyosaki N, Glasser SP, Young PM, MacCallum G, Gibson RS, Shook TL, Stone PH: Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation 1993;88:92-100.
63. James RG, Arnold JM, Allen JD, Pantridge JF, Shanks RG: The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation. Circulation 1977;55:311-317.
64. Reynolds RD, Calzadilla SV, Lee RV: Spontaneous heart rate, propranolol, and ischaemia-induced ventricular fibrillation in the dog. Cardiovasc Res 1978;12:653-658.
65. Bolli R, Fisher DJ, Entman ML: Factors that determine the occurrence of arrhythmias during acute myocardial infarction. Am Heart J 1986;111:261-270.
66. Heidland UE, Strauer BE: Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001;104:1477-1482.
67. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD: Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986;57:563-570.
68. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper G, Carabello BA: Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction. Circulation 2000;101:653-659.
69. Mulder P, Barbier S, Chagroui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C: Long-term heart rate reduction induced by the selective I f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674-1679.